The TELIGEN® ICD is the smallest, thinnest high-energy ICD in the world, featuring innovative new technologies with exceptional longevity. This full-featured device was designed, built and tested with patient safety and reliability in mind.
TELIGEN is designed to be used with the LATITUDE® Patient Management System, the most rapidly-adopted remote device management system.*
The smallest, thinnest, high-energy ICD in
the world
At 9.9 mm thin and only 31.5 cc, the TELIGEN ICD is a full-featured device, offering improved safety design and more flexible programming options compared to previous Boston Scientific devices to help promote appropriate therapy while providing excellent device longevity.
Kylie talks about how the size and thinness made her decision to be implanted with a TELIGEN device. Hear Kylie's story >>
High Energy and Programmable Shock Vectors
41 J of stored energy and programmable shock vectors help you manage high DFTs
Provides programmable V-TRIAD, RV Coil to Can (Hot Can), or RV Coil to RA Coil (Cold Can) shock vectors for increased programming flexibility around high DFTs
RV Pacing Options
Engineered to promote intrinsic ventricular conduction without dropping ventricular beats
AV Search + features an advanced algorithm designed to promote intrinsic conduction that is extendable to 400 ms, and is designed to provide back-up pacing for every beat.
Fixed or Dynamic AV Delays can be extended up to 400 ms for enhanced promotion of intrinsic conduction.
The LATITUDE System provides an RV% Pacing alert, designed to notify you that the RV pacing percentage has exceeded a user selected threshold.
Tachycardia Treatment Setup
Designed to provide appropriate therapy through enhanced sensing, expanded therapy options, a choice of rhythm discriminators, enhanced nominals, and remote monitoring and follow-up
TELIGEN provides a robust sensing algorithm that takes the best elements of Brady and Tachy sensing to form a common sensing algorithm with enhanced signal filtering and processing.
Quick Convert™ delivers a burst of ATP in the VF zone to avoid painful shocks for pace terminable VTs below 250 beats per minute.
TELIGEN offers a choice of rhythm discriminators between onset/stability or Rhythm ID to tailor therapy for each patient
TELIGEN is the first ICD to offer a 2-zone nominal therapy structure with ATP and rhythm discriminators nominally ON.
Integration with LATITUDE Patient Management System allows physicians following device status and patient health to remotely select their follow-up and monitoring schedules to maximize the efficiency of their practice
The LATITUDE System is compatible with HL7® industry standards and enables integration of device data into any electronic medical record
Assurance
Designed with patient safety and reliability in mind
Designed, built, and tested through Aurora, Boston Scientific Cardiac Rhythm Management’s continuous quality improvement program
Engineered for safety with rigorously tested self-correcting software and Safety Core™ redundant back-up hardware.
The LATITUDE system delivers confidence and assurance about device status through daily device checks.
*Based on number of patients reported at six quarters post launch.
C8-612
Compare TELIGEN to the competition in size and longevity estimates